Arcellx Inc (ACLX)
77.58
+0.79
(+1.03%)
USD |
NASDAQ |
Dec 24, 16:00
Arcellx Enterprise Value: 3.621B for Dec. 24, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Gilead Sciences Inc | 135.21B |
| Boston Scientific Corp | 142.85B |
| Johnson & Johnson | 366.61B |
| AbbVie Inc | 381.92B |
| Agios Pharmaceuticals Inc | 945.11M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -25.87M |
| Revenue (Quarterly) | 26.03M |
| Total Expenses (Quarterly) | 59.65M |
| EPS Diluted (Quarterly) | -0.48 |
| Profit Margin (Quarterly) | -99.37% |
| Earnings Yield | -0.92% |
| Normalized Earnings Yield | -0.9152 |